Category: Investigator news

New microbiome book highlights AllerGen research

A new book, describing the “seed-and-feed” process by which a baby’s gut microbiome is established, features AllerGen investigator Dr. Anita Kozyrskyj and her research using CHILD Study data. Written for the general public, Your Baby’s Microbiome: The Critical Role of

Posted in CHILD Study, Investigator news, Media coverage

CHILD Study in The Economist

The Economist magazine highlights the CHILD Study in its February 25, 2017, issue. The article, “Four good bugs,” profiles research led by AllerGen investigator Dr. Brett Finlay of The University of British Columbia, which looks at the relationship between gut

Posted in CHILD Study, Investigator news, Media coverage

Malcolm Sears: CHR Researcher of the Month

“An innate curiosity, rugged determination, keen power to intuit observations, and capacity to think and act outside the box”–these are a few qualities of AllerGen Research Leader Dr. Malcolm Sears highlighted by Canadians for Health Research (CHR) as they honour

Posted in Awards, Honours and Grants, CHILD Study, Investigator news

Study finds GO train riders exposed to high level of diesel exhaust

A study co-authored by AllerGen investigator Dr. Greg Evans, a University of Toronto professor of chemical engineering and director of the Southern Ontario Centre for Atmospheric Aerosol Research (SOCAAR), has found that passengers travelling in diesel-powered commuter GO trains risk

Posted in Investigator news

Dr. Malcolm Sears, Dunedin Study featured in documentary series

AllerGen Research Leader Dr. Malcolm Sears is featured in a 2016 documentary series chronicling the lives of 1,037 people born in Dunedin, New Zealand during 1972-73. The series, Predict My Future: The Science of Us, reveals the fascinating findings from

Posted in Investigator news, Media coverage

Dr. Michael Kobor appointed to BC Leadership Chair

AllerGen Research Leader Dr. Michael Kobor, a Professor of Medical Genetics and Canada Research Chair in Social Epigenetics at The University of British Columbia, has been appointed to the Sunny Hill BC Leadership Chair in Child Development. The Chair provides

Posted in Awards, Honours and Grants, Investigator news

AllerGen investigators honoured by CSACI

Two AllerGen investigators were honoured at the Awards Dinner of the 2016 Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting held September 29 – October 2, 2016, in Montreal, QC. Dr. Bruce Mazer (McGill University) received the

Posted in Awards, Honours and Grants, Investigator news, Partner news

AllerGen Research Leader heads major urban health project

AllerGen Research Leader Dr. Jeffrey Brook is Scientific Director and Nominated-Principal Investigator on a new five-year, $4.16 million Operating Grant from the CIHR’s Environments and Health Signature Initiative. The project, CANadian Urban Environmental (CANUE) Health Research Consortium, aims to advance

Posted in Awards, Honours and Grants, CHILD Study, Investigator news

Dr. Bruce Mazer named interim head of RI-MUHC

AllerGen investigator Dr. Bruce Mazer has been designated Interim Executive Director and Chief Scientific Officer (CSO) of the Research Institute of the McGill University Health Centre (RI-MUHC). His appointment will be effective from October 1, 2016, until a new Executive

Posted in Announcements, Awards, Honours and Grants, Investigator news

AllerGen’s Scientific Director appointed as Canadian Academy of Health Sciences Fellow

Dr. Judah Denburg, Scientific Director and CEO of AllerGen, was inducted as a Fellow of the Canadian Academy of Health Sciences (CAHS) at the CAHS Annual General Meeting in Montreal on September 15, 2016. Election to fellowship in the CAHS

Posted in Awards, Honours and Grants, Investigator news

AllerGen researchers find possible key to fibrosis in mouse model of Crohn’s disease

New research by AllerGen investigators at The University of British Columbia (UBC) has found that a group of immune cells known as Group 3 innate lymphoid cells (ILC3) could be the key to the development of fibrosis in a mouse

Posted in Investigator news, Publications/Research updates

Mohsen Sadatsafavi receives CIHR New Investigator award

Health outcomes researcher and AllerGen research collaborator Dr. Mohsen Sadatsafavi has been awarded a New Investigator Salary Award, valued at $300,000 over five years (2016-2021), by the Canadian Institutes of Health Research (CIHR). The award will support Dr. Sadatsafavi’s work

Posted in Awards, Honours and Grants, Investigator news